Heart conditions, cardiac medicines and supplements: what the evidence says on safety
posted on
By UTCardiothoracicSurgery.com Editorial Team Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice. Consult a licensed healthcare provider …
Continue Reading about 50 Days to Approval: Why GLP-1 Pills Still Disappoint Some Patients →
posted on
By UTCardiothoracicSurgery.com Editorial Team Disclaimer: This article is educational only and does not constitute medical advice. Treatment decisions for obesity and related conditions require …
Continue Reading about Obesity and Weight-Related Comorbidities: Why the Right Treatment Matters →
posted on
By UTCardiothoracicSurgery.com Editorial Team Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. …
Continue Reading about Foundayo (Orforglipron) 2026: Is It Legit for Weight Loss? →
posted on
Medically reviewed by the UTCardiothoracicSurgery.com editorial team | Published April 2026 Disclaimer: This article is for educational purposes only and doesn't constitute medical advice. Never stop …
posted on
Medically reviewed by the UT Cardiothoracic Surgery editorial team | Published April 2026 Disclaimer: This article is for educational purposes only and doesn't constitute medical advice. Eligibility …
posted on
As of October 1, 2026, two oral GLP-1 pills are FDA-approved for weight management in adults: Wegovy tablets (semaglutide) and Foundayo (orforglipron), which FDA approved on April 1, 2026. Foundayo is …
Continue Reading about Oral GLP-1 Pills 2026: Foundayo, Wegovy Pill, Cost & Coverage →